Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells

Publisher： Spandidos Publications

E-ISSN： 1791-2423|46|1|78-90

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.1, 2015-01, pp. : 78-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autologous tumor vaccines processed to express α-gal epitopes: a practical approach to immunotherapy in cancer

By Galili Uri  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 935-945

Springer Publishing Company

Access to resources Recommend Favorite

Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition

By                  

International Journal of Oncology, Vol. 41, Iss. 6, 2012-01 ,pp. : 2093-2102

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis

By Han Lu   Chen Wei   Zhao Qicheng  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2473-2480

Springer Publishing Company

Access to resources Recommend Favorite

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokineinduced killer cell therapy in hepatobiliary and pancreatic cancer

By              

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 129-133

Science Publishers

Access to resources Recommend Favorite

Pancreatic Cancer

By  

International Journal of Gastrointestinal Cancer, Vol. 25, Iss. 1, 1999-02 ,pp. : 69-70

Humana Press, Inc

Access to resources Recommend Favorite